![Avery Catlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Avery Catlin
Direttore/Membro del Consiglio presso
Corbus Pharmaceuticals, Inc.
Profilo
Avery W.
Catlin is currently the Director at Corbus Pharmaceuticals, Inc. and the Vice President at CuraGen Corp.
Previously, he served as the Independent Director at Provention Bio, Inc. from 2018 to 2023 and at Corbus Pharmaceuticals Holdings, Inc. from 2014 to 2024.
He also held the position of Chief Financial Officer at MediSense, Inc. and Repligen Corp.
from 1992 to 1996 and Chief Financial Officer & VP-Operations at Endogen, Inc. from 1996 to 1999.
From 2000 to 2008, he was the Chief Financial Officer, Secretary & SVP at AVANT Immunotherapeutics, Inc. and from 2011 to 2017, he served as the CFO, Secretary, Treasurer & Senior Vice President at Celldex Therapeutics, Inc. Mr. Catlin completed his undergraduate degree at the University of Virginia and holds an MBA from Babson College.
Posizioni attive di Avery Catlin
| Società | Posizione | Inizio |
|---|---|---|
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Corporate Officer/Principal | - |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Operates as a biopharmaceutical company | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Avery Catlin
| Società | Posizione | Fine |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Direttore/Membro del Consiglio | 15/08/2024 |
| PROVENTION BIO, INC. | Direttore/Membro del Consiglio | 27/04/2023 |
| CELLDEX THERAPEUTICS, INC. | Direttore Finanziario/CFO | 30/06/2017 |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Direttore Finanziario/CFO | 01/10/2008 |
Endogen, Inc.
 Endogen, Inc. Medical SpecialtiesHealth Technology Makes reagents & immuno-assay test kits | Direttore Finanziario/CFO | 01/01/1999 |
Formazione di Avery Catlin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
36
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
MediSense, Inc.
 MediSense, Inc. Provides blood-glucose monitoring systems | |
Repligen Corp.
 Repligen Corp. Develops and manufactures biologic drugs | |
Endogen, Inc.
Endogen, Inc. Medical SpecialtiesHealth Technology Makes reagents & immuno-assay test kits | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Operates as a biopharmaceutical company | |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | |
Provention Bio, Inc.
 Provention Bio, Inc. Develops drugs that focused on the prevention and interception of immune-mediated disease |
